Physician profile
Dicken Ko
NPI 1083604219
$158,128.04
in general payments reported to CMS, 2019-2025
20 companies · $53K in 2025
The $53K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $20.11 · 2021: $29K · 2022: $8,002 · 2023: $29K · 2024: $39K · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $70K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $39K · Travel and Lodging: $9,600 · Food and Beverage: $2,701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $69,538.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $38,598.25 |
| Travel and Lodging | $9,599.54 |
| Food and Beverage | $2,700.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $83,858.26 | 2021-2025 | 1788, S3, Na |
| Sanofi-Aventis U.S. LLC | $54,900.12 | 2021-2025 | |
| Genzyme Corporation | $11,963.52 | 2023-2025 | |
| Gyrus Acmi, INC. | $4,250.00 | 2025 | Soltive, Medical Control Unit For Endosurgery Uces-4 |
| Medtronic, INC. | $1,438.00 | 2023 | |
| Boston Scientific Corporation | $299.16 | 2019-2021 | |
| Veloxis Pharmaceuticals, INC. | $230.47 | 2021-2022 | |
| Zoll Medical Corporation | $175.00 | 2024 | Defibrillator |
| Angiodynamics, INC. | $165.59 | 2025 | Nanoknife |
| Teleflex LLC | $161.74 | 2022 | |
| Olympus America INC. | $131.69 | 2022 | |
| Intuitive Surgical, INC. | $128.21 | 2019 | |
| Steris Corporation | $123.26 | 2023 | |
| Amgen INC. | $121.19 | 2019-2023 | Parsabiv |
| Neotract INC. | $44.94 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $40.61 | 2021 | |
| Astellas Pharma US INC | $39.82 | 2022 | |
| Metuchen Pharmaceuticals | $21.98 | 2019 | |
| Dentsply Ih INC. | $20.11 | 2020 | |
| Axonics, INC. | $14.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dicken Ko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.